TVRD
Tvardi Therapeutics
TVRD
TVRD
127 hedge funds and large institutions have $307M invested in Tvardi Therapeutics in 2017 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.01% less ownership
Funds ownership: 1.72% → 1.7% (-0.01%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
43% less call options, than puts
Call options by funds: $20.6M | Put options by funds: $36.2M
Holders
127
Holding in Top 10
2
Calls
$20.6M
Puts
$36.2M
Top Buyers
| 1 | +$43.6M | |
| 2 | +$8.08M | |
| 3 | +$4M | |
| 4 |
BlackRock
New York
|
+$3.61M |
| 5 |
Morgan Stanley
New York
|
+$3M |
Top Sellers
| 1 | -$18.4M | |
| 2 | -$7.08M | |
| 3 | -$5.52M | |
| 4 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
-$2.76M |
| 5 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$2.76M |